Point72 Hong Kong LTD Akebia Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.72 - $2.93 $9,436 - $38,400	-13,106 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.26 - $3.34 $29,619 - $43,774	13,106 New	13,106 $30,000
Q3 2021 Nov 15, 2021	SELL	$2.35 - $3.88 $43,359 - $71,589	-18,451 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.83 - $4.2 $48,013 - $71,257	16,966 Added 1142.49%	18,451 $70,000
Q1 2021 May 17, 2021	SELL	$2.92 - $5.06 $10,964 - $19,000	-3,755 Reduced 71.66%	1,485 $5,000
Q4 2020 Feb 16, 2021	BUY	$2.22 - $3.78 $8,291 - $14,118	3,735 Added 248.17%	5,240 $15,000
Q3 2020 Nov 16, 2020	BUY	$2.39 - $13.08 $3,596 - $19,685	1,505 New	1,505 $4,000
Q2 2020 Aug 14, 2020	SELL	$6.67 - $13.58 $13,400 - $27,282	-2,009 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$4.1 - $10.24 $3,972 - $9,922	969 Added 93.17%	2,009 $15,000
Q4 2019 Feb 14, 2020	BUY	$3.16 - $6.73 $2,825 - $6,016	894 Added 612.33%	1,040 $7,000
Q3 2019 Nov 14, 2019	SELL	$3.55 - $5.4 $9,372 - $14,256	-2,640 Reduced 94.76%	146 $1,000
Q2 2019 Aug 14, 2019	BUY	$4.1 - $8.05 $11,422 - $22,427	2,786 New	2,786 $13,000
Q3 2018 Nov 14, 2018	SELL	$7.44 - $10.65 $3,467 - $4,962	-466 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$9.15 - $11.34 $40,104 - $49,703	-4,383 Reduced 90.39%	466 $5,000
Q1 2018 May 15, 2018	BUY	$9.53 - $15.68 $46,210 - $76,032	4,849 New	4,849 $46,000

177

108M

134K

262K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $373M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.